$196.48
0.39% yesterday
NYSE, Sep 18, 10:04 pm CET
ISIN
US98978V1035
Symbol
ZTS
Sector
Industry

Zoetis, Inc. Class A Stock price

$196.48
+12.00 6.50% 1M
+25.79 15.11% 6M
-0.89 0.45% YTD
+16.83 9.37% 1Y
-2.14 1.08% 3Y
+73.24 59.43% 5Y
+159.78 435.37% 10Y
NYSE, Closing price Wed, Sep 18 2024
+0.77 0.39%
ISIN
US98978V1035
Symbol
ZTS
Sector
Industry

Key metrics

Market capitalization $89.02b
Enterprise Value $94.18b
P/E (TTM) P/E ratio 38.47
EV/FCF (TTM) EV/FCF 44.78
EV/Sales (TTM) EV/Sales 10.56
P/S ratio (TTM) P/S ratio 9.98
P/B ratio (TTM) P/B ratio 17.96
Dividend yield 0.80%
Last dividend (FY23) $1.56
Revenue growth (TTM) Revenue growth 8.43%
Revenue (TTM) Revenue $8.92b
EBIT (operating result TTM) EBIT $3.21b
Free Cash Flow (TTM) Free Cash Flow $2.10b
Cash position $1.57b
EPS (TTM) EPS $5.11
P/E forward 35.90
P/S forward 9.65
EV/Sales forward 10.21
Short interest 1.13%
Show more

Is Zoetis, Inc. Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Zoetis, Inc. Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Zoetis, Inc. Class A forecast:

15x Buy
79%
4x Hold
21%

Analyst Opinions

19 Analysts have issued a Zoetis, Inc. Class A forecast:

Buy
79%
Hold
21%

Financial data from Zoetis, Inc. Class A

Jun '24
+/-
%
Net Profit 624 624
7% 7%
26%
Depreciation and Amortization 127 127
5% 5%
5%
Stock Compensation 19 19
12% 12%
1%
Operating Cash Flow 502 502
174% 174%
21%
Investments 132 132
20% 20%
6%
Dividend Paid 197 197
14% 14%
8%
Free Cash Flow 370 370
2,076% 2,076%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Zoetis, Inc. Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zoetis, Inc. Class A Stock News

Neutral
Seeking Alpha
14 days ago
Zoetis Inc (NYSE:ZTS ) Morgan Stanley 22nd Annual Global Healthcare Conference September 4, 2024 1:05 PM ET Company Participants Kristin Peck - Chief Executive Officer Wetteny Joseph - Chief Financial Officer Conference Call Participants Erin Wright - Morgan Stanley Erin Wright Thanks, and good afternoon, everyone. Welcome to the Morgan Stanley Healthcare Conference.
Positive
Seeking Alpha
15 days ago
The SPDR S&P 500 ETF Trust posted a 2.34% gain in August, underperforming Vanguard's Dividend Appreciation Index Fund ETF Shares by +3.32%. The top 15 dividend growth stocks for September 2024 offer an average dividend yield of 1.23% and appear to be about 26% undervalued based on dividend yield theory. Since its inception in September 2020, the watchlist has achieved a 12.93% annualized return.
Neutral
Business Wire
30 days ago
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. Kristin Peck, Chief Executive Officer, and Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 1:05 p.m. ET. Investo...
More Zoetis, Inc. Class A News

Company Profile

Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

Head office United States
CEO Kristin Peck
Employees 14,100
Founded 1952
Website www.zoetis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today